pyridoxamine has been researched along with Glaucoma in 1 studies
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggest that the elevated iso[4]LGE(2) protein adduct immunoreactivity observed in glaucomatous astrocytes may be due to chronic and/or prolonged exposure to pressure, and pyridoxamine may have prophylactic utility against such oxidative protein modification." | 3.75 | Increased isolevuglandin-modified proteins in glaucomatous astrocytes. ( Algeciras, M; Bhattacharya, SK; Govindarajan, B; Junk, A; Salomon, RG, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Govindarajan, B | 1 |
| Junk, A | 1 |
| Algeciras, M | 1 |
| Salomon, RG | 1 |
| Bhattacharya, SK | 1 |
1 other study available for pyridoxamine and Glaucoma
| Article | Year |
|---|---|
Increased isolevuglandin-modified proteins in glaucomatous astrocytes.
Topics: Aged; Aged, 80 and over; Animals; Astrocytes; Cerebral Cortex; Child; Fatty Acids, Unsaturated; Fema | 2009 |